This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2020 Oct;133(10):1116-1117.

doi: 10.1016/j.amjmed.2020.05.006. Epub 2020 Jun 2.

Further Insights into Type 2 Myocardial Infarction

Joseph S Alpert¹

Affiliations

Affiliation

¹ Department of Medicine, University of Arizona College of Medicine, Sarver Heart Center, Tucson; Editor in Chief, The American Journal of Medicine. Electronic address: jalpert@shc.arizona.edu.

PMID: 32502484
DOI: 10.1016/j.amjmed.2020.05.006

Editorial

Further Insights into Type 2 Myocardial Infarction

Joseph S Alpert. Am J Med. 2020 Oct.

. 2020 Oct;133(10):1116-1117.

doi: 10.1016/j.amjmed.2020.05.006. Epub 2020 Jun 2.

Author

Joseph S Alpert¹

Affiliation

¹ Department of Medicine, University of Arizona College of Medicine, Sarver Heart Center, Tucson; Editor in Chief, The American Journal of Medicine. Electronic address: jalpert@shc.arizona.edu.

PMID: 32502484
DOI: 10.1016/j.amjmed.2020.05.006

No abstract available

PubMed Disclaimer

Comment on

A Comparison of Biomarker Rise in Type 1 and Type 2 Myocardial Infarction.
Pandey AK, Duong T, Swiatkiewicz I, Daniels LB. Pandey AK, et al. Am J Med. 2020 Oct;133(10):1203-1208. doi: 10.1016/j.amjmed.2020.02.024. Epub 2020 Mar 29. Am J Med. 2020. PMID: 32234496

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information